Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The enhancer for the immunoglobulin mu heavy chain gene (IgH) activates a heterologous gene at the pre-B cell stage of B lymphocyte differentiation. A lymphoid-specific element, microB, is necessary for enhancer function in pre-B cells. A microB binding protein is encoded by the PU.1/Spi-1 proto-oncogene. Another sequence element, microA, was identified in the mu enhancer that binds the product of the ets-1 proto-oncogene. The microA motif was required for microB-dependent enhancer activity, which suggests that a minimal B cell-specific enhancer is composed of both the PU.1 and Ets-1 binding sites. Co-expression of both PU.1 and Ets-1 in nonlymphoid cells trans-activated reporter plasmids that contained the minimal mu enhancer. These results implicate two members of the Ets family in the activation of IgH gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In case of the B-lymphoid genes such as Ig heavy chain (μ) [34], Ig light chains (κ and λ) [35, 36], mb- (Ig α) [37], B29 (Ig β) [38] and Ig-J chain [33], the binding of PU.1 to the enhancer regions induces the bending of DNA that facilitates the binding of other transcription factors to their respective binding sites, thus forming a synergistic multiprotein-complex to augment transcription.”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [34]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Self-citationThe c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S., et al. (1991) · Science · doi:10.1126/science.1846704 · Cited by 1,572
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Self-citationLopata, M. A., Cleveland, D. W., & Sollner-Webb, B. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5707 · Cited by 822
B Lineage—Specific Interactions of an Immunoglobulin Enhancer with Cellular Factors in Vivo
Ephrussi, A., Church, G. M., Tonegawa, S., & Gilbert, W. (1985) · Science · doi:10.1126/science.3917574 · Cited by 796
Developmentally controlled and tissue-specific expression of unrearranged VH gene segments
Yancopoulos, G. (1985) · Cell · doi:10.1016/0092-8674(85)90141-2 · Cited by 696
Protein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility
Lenardo, M., Pierce, J. W., & Baltimore, D. (1987) · Science · doi:10.1126/science.3109035 · Cited by 578
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
Self-citation
Cited by
Items 201–217 of 217
Kirkham, C. M., Scott, J. N., Boyes, J., & Bevington, S. L. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-45198-0_13 · Cited by 1
Examining the effect of CBP on the E2A-PBX1 and HOXB4 interaction
Menezes, S. C. (2008)
Samara, M. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
ETS transcription factor knockouts: A review
Bassuk, A. G. (1999) · Clinical Immunology Newsletter · doi:10.1016/s0197-1859(00)89197-9
LaVallee, T. M., & Morrison, S. L. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00036-3 · Cited by 1
de Walque, S., Vanhulle, C., Vandenhoudt, N., Driessche, B. V., Burny, A., & Lint, C. M. V. (2006) · Retrovirology · doi:10.1186/1742-4690-3-s1-s41
Transcription Regulation in B-cell Development
Ishii, H., Chowdhury, D., & Sen, R. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50098-5
Self-citationKamath, M. B. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Stereochemical Considerations of Immunoglobulin Heavy Chain Enhancer Activation
Sen, R., & Nikolajczyk, B. S. (1999) · CRC Press eBooks · doi:10.1201/9780203909607.ch17
Self-citationAnalysis of gene regulation in transgenic mouse models
Wirth, T. (1996) · Elsevier eBooks · doi:10.1016/b978-012442710-5.50040-x
Silencing Immunoglobulin Gene Enhancers as a Potential Treatment Strategy for Multiple Myeloma
Toman, I., Loree, J. M., Duerksen, K., Evans, R. P., & Reiman, T. (2008) · Blood · doi:10.1182/blood.v112.11.5162.5162
Cut-and-run: a new mechanism by which V(D)J recombination could trigger leukaemia and lymphoma
Kirkham, C. M. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Batista, C. R., & DeKoter, R. P. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101960-1
Editorial: Epigenetics and genomic causality in development and chromatin research
Rothenberg, E. V., & Deichmann, U. (2025) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2025.1564074
Rôle du facteur de transcription ETS1 dans la différenciation des lymphocytes B
Gama, L. (2022) · theses.fr (ABES) · doi:10.70675/ffaf98a1z4fa8z49a7zbe9fz83a1f3e26bf4
Metadata
- Authors
- Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R.
- Affiliations
- Brandeis University (US)
- University of Utah (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Venue
- Science
- Published
- 1993-07-02
- Volume
- 261
- Issue
- 5117
- Pages
- 82-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2041497115
- Cited by
- 222
- References
- 34
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2017: 5 · 2016: 1 · 2015: 1 · 2014: 3 · 2012: 3
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k04gm000563-03)
- National Institute of General Medical Sciences (GM 38663, GM-38925, 1K04GM00563)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- enhancer regulation, ETS transcription factors, ETS1, pre-B cell differentiation, B cell development, transcriptional activation
- MeSH terms
- Proto-Oncogene Mas, Animals, B-Lymphocytes, Base Sequence, Binding Sites, Cell Differentiation, Cell Line, DNA-Binding Proteins, Enhancer Elements, Genetic, Female, Genes, Immunoglobulin, Humans, Immunoglobulin mu-Chains, Molecular Sequence Data, Mutation, Proto-Oncogene Proteins, Transcription Factors, Retroviridae Proteins, Oncogenic, Proto-Oncogene Proteins c-ets, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.